Related Experiment Videos

[Neutropenia with fever]

A Ben Ali1

  • 1Laboratoire de Microbiologie médicale, Fondation Hôpital Saint-Joseph, Paris.

Presse Medicale (Paris, France : 1983)
|December 22, 1999
PubMed

Insights

Infections in neutropenic patients are shifting towards Gram-positive bacteria, while multidrug-resistant Gram-negative infections remain a significant concern. Careful antibiotic selection based on susceptibility data is crucial for improving patient outcomes.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Microbiology

Context:

  • Neutropenic patients in hematology units experience evolving infection patterns.
  • Increasing incidence of Gram-positive bacterial infections observed over the past decade.
  • Persistent high rates of sepsis caused by multidrug-resistant Gram-negative bacteria, including Pseudomonas aeruginosa and Strenotrophomonas maltophilia.

Purpose:

  • To analyze the changing landscape of causative pathogens in neutropenic patients.
  • To emphasize the critical role of antibiotic regimen efficacy in managing septic episodes.
  • To highlight the necessity of incorporating antimicrobial susceptibility data into treatment protocols.

Summary:

  • Hematology units have noted a significant shift in infection epidemiology among neutropenic patients over the last 10 years.
  • There is a documented rise in infections attributed to Gram-positive bacteria.
  • Concurrently, the incidence of bloodstream infections (septicemia) caused by multidrug-resistant Gram-negative pathogens remains a persistent challenge.

Impact:

  • Effective management of septic episodes is paramount for improving the prognosis of neutropenic patients.
  • The efficacy of antibiotic regimens directly correlates with the risk of developing sepsis.
  • Antimicrobial susceptibility data are essential for developing evidence-based antibiotic protocols in neutropenic patient care settings.

Related Concept Videos